[Autoimmune hemolytic anemia in children]

Area of Science:

• Pediatrics
• Immunology
• Hematology

Background:

• Autoimmune hemolytic anemia (AIHA) is a rare pediatric condition.
• It is characterized by immune-mediated destruction of red blood cells (RBCs) due to autoantibodies.
• The specific autoantibodies dictate the clinical presentation and classification of AIHA.

Purpose of the Study:

• To provide a comprehensive overview of pediatric autoimmune hemolytic anemia.
• To discuss the distinct features of AIHA in children compared to adults.
• To review the epidemiology, etiology, clinical presentation, laboratory evaluation, and treatment options for different AIHA classifications.

Main Methods:

• This is a review article.
• Information was gathered from existing literature on pediatric autoimmune hemolytic anemia.
• The review categorizes AIHA into warm autoimmune hemolytic anemia, cold autoimmune hemolytic anemia, and paroxysmal cold hemoglobinuria.

Main Results:

• Pediatric AIHA presents with diverse clinical entities based on autoantibody characteristics.
• Key classifications include warm AIHA, cold AIHA, and paroxysmal cold hemoglobinuria.
• Each classification has unique epidemiological, etiological, clinical, and therapeutic profiles.

Conclusions:

• Understanding the specific classification of pediatric AIHA is crucial for effective management.
• This review consolidates essential information for clinicians diagnosing and treating AIHA in children.
• Further research may elucidate more targeted therapeutic strategies for pediatric AIHA subtypes.